Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Influenza Clinical Trials

A listing of Influenza medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (83) clinical trials

The purpose of this study is to compare the effects of an experimental drug to see if it is better at treating flu infections. This study will include approximately 7 visits to the research center. Qualified participants may receive study medications and all study related care including physical examinations and ...

Phase N/A

Fever? Aches? Pains? Cough? Sore Throat? When you reach for the tissues this flu season, think Mount Vernon Clinical Research. Mount Vernon Clinical Research is enrolling in a study that will try to find out if an investigational flu drug can speed up the recovery of people with flu. Eligibility ...

Phase N/A

Seasonal Influenza Vaccine Quadrivalent Versus Trivalent in Patients With Advanced Chronic Obstructive Pulmonary Disease

Primary Objectives: To evaluate the magnitude of the humoral immune responses to quadrivalent vs trivalent influenza vaccines in adults between the age of 50 and 64 years with a prior diagnosis of GOLD Stage C and D COPD (vs. those patients without COPD). To demonstrate immunogenicity by measuring hemagglutination inhibiting ...

Phase

Clinical Trial to Assess the Influenza Vaccination for Seasonal 2013-2016

Influenza vaccination strategies aim at protecting high-risk population from severe outcomes. Estimating the effectiveness of seasonal vaccines against influenza related hospitalisation is important to guide these strategies. The objective is to measure the population effectiveness of influenza vaccine in patients hospitalized with virologically confirmed influenza laboratory during 3 influenza seasons ...

Phase N/A

Clinical Trial of Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in Children

The study shall enroll outpatient subjects of both sexes aged 3-12 years with clinical manifestations of influenza/Acute Respiratory Viral Infections (ARVI), including fever of at least 38.0 , who sought medical aid within the first day of the illness onset. he doctor shall collect medical history information, perform an objective ...

Phase

Banlangen Granules Anti-seasonal Influenza Study

Inclusion criteria: Patients have confirmed influenza A(H1N1,H3N2) or influenza B virus infection by real time PCR age between 18-65 years old axillary temperature 38C and with at least two constitutional symptoms (headache, chill, myalgia or fatigue) and one respiratory symptom (cough sore throat,or coryza) . Illness onset had to be ...

Phase

A Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults

This is a study to test new vaccine formulations against pandemic avian influenza ("bird flu"). Bird flu is a potentially deadly disease that is caused by influenza virus from birds. It is not the same as the common seasonal flu for which there is a seasonal vaccine released around March ...

Phase

Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects

The primary objective of the study is to evaluate the time to resolution of influenza symptoms in adults with acute uncomplicated seasonal influenza A following administration of VX-787, with and without concomitant oseltamivir.

Phase

Safety PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza

This study will evaluate the safety, pharmacokinetics and effectiveness of a single dose of IV peramivir compared to a standard 5 day course of oral oseltamivir in the treatment of pediatric subjects with acute uncomplicated influenza. Two thirds of the participants will receive peramivir, while one third will receive oseltamivir.

Phase

The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection)

Treatment group: Fuganlin Oral Liquid 10mL. Control group: Xiaoer Jiebiao oral liquid 100mL. Treatment for one week. Patients who were recovered within one week can withdrawal at any time.

Phase